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ABSTRACT 23 
 High prevalence of Kaposi’s sarcoma (KS) is seen in diabetic patients.  It is 24 
unknown if the physiological condition of diabetes contributes to KS development.  We 25 
found elevated levels of viral lytic gene expression when Kaposi’s sarcoma-associated 26 
herpesvirus (KSHV) infected cells were cultured in high glucose medium. To 27 
demonstrate the association between high glucose and KSHV replication, we xeno-28 
grafted telomerase-immortalized human umbilical vein endothelial cells that are infected 29 
with KSHV (TIVE-KSHV) into hyperglycemic and normal nude mice. The injected cells 30 
expressed significantly higher levels of KSHV lytic genes in hyperglycemic mice than in 31 
normal mice. We further demonstrated that high glucose induced production of hydrogen 32 
peroxide (H2O2), which down regulated silent information regulator 1 (SIRT1), a class-III 33 
histone deacetylase (HDAC), resulting in epigenetic transactivation of KSHV lytic genes.  34 
These results suggest that high blood glucose in diabetic patients contributes to 35 
development of KS by promoting KSHV lytic replication and infection.    36 
 37 
AUTHORS’ SUMMARY 38 
 Multiple epidemiological studies have reported a higher prevalence of classic KS 39 
in diabetic patients.  By using both in vitro and in vivo models, we demonstrated an 40 
association between high glucose and KSHV lytic replication.  High glucose induces 41 
oxidative stress and production of H2O2, which mediates reactivation of latent KSHV 42 
through multiple mechanisms.  Our results provide the first experimental evidence and 43 
mechanistic support for the association of classic KS with diabetes. 44 
45 
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INTRODUCTION 46 
Kaposi sarcoma (KS) is a vascular neoplasia etiologically associated with 47 
Kaposi’s sarcoma-associated herpesvirus (KSHV) infection (1). KSHV establishes a life-48 
long persistent latent infection following acute infection.   Reactivation of the latent virus 49 
into productive lytic replication plays a pivotal role in the initiation and progression of 50 
KS as viral load positively correlates with KS progression. Indeed, treatment of KS 51 
patients with anti-herpesviral drugs effectively leads to regression of KS tumors (2-6).  52 
Unlike iatrogenic or AIDS-associated KS, classic KS predominantly occurs in 53 
elderly men of Mediterranean or Jewish decent, with no apparent immune suppression 54 
(7).  The exact cause for the development of classic KS remains undefined.  Asthma, 55 
allergies in males, topical corticosteriod use, and infrequent bathing have been suggested 56 
as risk factors for classic KS (8-9).  Multiple studies have also documented a high 57 
prevalence of classic KS in patients with diabetes mellitus (10-13), a metabolic syndrome 58 
that manifests with elevated levels of blood glucose and episodic ketoacidosis, either due 59 
to a lack of insulin (Type-1 diabetes) or cellular resistance to insulin (Type-2 diabetes).  60 
High levels of KSHV DNA and sero-positivity have been seen in diabetic patients (14-61 
16).  However, no study has ever determined if diabetes is the cause or effect of KS and 62 
whether high glucose level plays a role in the development of KS.   63 
In the present study, we found increased levels of viral lytic gene expression when 64 
KSHV–infected primary effusion lymphoma cells were cultured in medium containing 65 
high levels of glucose.  To further examine the association between high blood glucose 66 
and KSHV replication, we generated hyperglycemic nude mice with streptozotocin 67 
(STZ), which damages pancreatic β cells to result in hypoinsulinemia and hyperglycemia 68 
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(17).  We then xeno-grafted telomerase-immortalized human umbilical vein endothelial 69 
cells (18) that are re-infected with a recombinant Kaposi’s sarcoma-associated 70 
herpesvirus [TIVE-KSHV (BAC16)] (19), into the hyperglycemic and control healthy 71 
nude mice.  The original TIVE-KSHV cells were malignantly transformed and grow 72 
“KS-like” tumors in nude mice (18). Although hyperglycemia did not seem to enhance 73 
tumor growth, the injected TIVE-KSHV (BAC16) cells expressed significantly higher 74 
levels of KSHV lytic genes in hyperglycemic mice than in normal mice.  Results from 75 
cells cultured in vitro demonstrate that high glucose induces production of H2O2, which 76 
has been previously shown to trigger reactivation of latent KSHV through activation of 77 
the MAKP pathways (20-21).  Interestingly, H2O2 also mediates down regulation of the 78 
class-III HDAC SIRT1 (22) to induce histone hyperacetylation of viral chromatins, 79 
resulting in active transcription of KSHV lytic genes.  Our results suggest that H2O2 80 
mediates high glucose induction of KSHV lytic gene expression and replication through 81 
multiple mechanisms.   82 
To our knowledge, this study provides the first experimental evidence to support 83 
an association of diabetes with development of KS that has been suggested by previous 84 
epidemiological studies.  85 
 86 
MATERIALS and METHODS 87 
Cell culture, media, and reagents 88 
 TIVE-KSHV cells, originally infected with native KSHV (18), were cultured in 89 
Dulbecco’s Modified Eagle Medium (DMEM) medium plus 10% fetal bovine serum 90 
(FBS).  We re-infected these cells with the recombinant KSHV BAC16 to obtain TIVE-91 
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KSHV (BAC16) cells that stably express green fluorescence protein (GFP). RPMI 1640 92 
medium without glucose was purchased from ThermoFisher Scientific (Waltham, 93 
Massachusetts, USA). BCBL1 cells were grown in RPMI 1640 medium with 1, 3, or 6 94 
g/L D-glucose plus 10% FBS.  Primary human umbilical vein endothelial cells 95 
(HUVECs) were grown in EBM-2 medium with growth factor supplements (Lonza, 96 
Allendale, New Jersey, USA). 97 
 A mouse monoclonal antibody to KSHV lytic protein RTA was a gift from the 98 
Pasteur Research Institute in Shanghai, China. A mouse monoclonal antibody to KSHV 99 
lytic protein K8α was purchased from MyBiosource, Inc. (San Diego, California, USA). 100 
A rat antibody to KSHV latent nuclear antigen (LANA) was purchased from Advanced 101 
Biotechnologies, Inc. (Columbia, Maryland, USA). A mouse monoclonal antibody to 102 
SIRT1 was purchased from EMD Millpore (Temecula, California, USA). D-glucose and 103 
L-glucose were purchased from Sigma-Aldrich.   104 
 105 
Generation of hyperglycemic mice and xeno-grafting of TIVE-KSHV (BAC16) cells 106 
 A total number of 32 athymic nude mice (4 week old, female) were purchased 107 
from Jackson Laboratory (Bar Harbor, ME, USA). The blood glucose level of each 108 
mouse was measured before any treatment by using a glucose meter.  The mice were then 109 
randomly separated into two groups, one being treated with intra-peritoneal (IP) injection 110 
of Streptozotocin (STZ, Sigma-Aldrich) at a dose of 200 mg/kg body mass, twice a week 111 
for 2 weeks. The other group of untreated mice was used as a control. Two weeks after 112 
the last STZ treatment, the blood glucose level of each mouse from both groups was 113 
measured again to confirm development of hyperglycemia in the treated mice. Equal 114 
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numbers of TIVE-KSHV (BAC16) cells at 5 x 106 cells per injection site, 2 sites per 115 
mouse, were then subcutaneously injected into each mouse at the abdominal region. 116 
Tumor volumes (length x width x height) were measured once a week with a caliper.  At 117 
the end of experiments, all tumors were surgically removed from the mice. All 118 
procedures were carried out in strict accordance with the recommendations in the Guide 119 
for the Care and Use of Laboratory Animals of the National Institutes of Health and 120 
following a protocol (2011-0802) that was approved by the Institutional Animal Care and 121 
Use Committee (IACUC) at Case Western Reserve University.  122 
 123 
Immuno-chemical staining and imaging 124 
 Fresh frozen sections were prepared from the surgically removed tumors.  A 125 
standard procedure for preparation and staining of acetone-fixed frozen tissue sections 126 
was followed, using primary antibodies to KSHV small capsid protein (ORF65), latent 127 
protein LANA, and control IgG.  After multiples washes with PBS, the primary antibody-128 
antigen signals were revealed with a biotinylated secondary antibody and streptavidin-129 
horseradish peroxidase, and DAB (3,3’-diaminobenzidine) detection system (Biolegend, 130 
San Diego, California, USA). DAPI was used for nuclear staining.  Images were captured 131 
under a microscope (Carl Zeiss, Inc., Thornwood, NY).  132 
 133 
Isolation of Total RNAs and Quantification of mRNA by qRT-PCR   134 
 Total RNAs were isolated using a RNA purification kit from QIAGEN, which 135 
includes a step to remove residual genomic DNA prior to RNA purification. Reverse 136 
transcription (RT) of total RNA was performed by using Superscript Transcriptase II 137 
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(Invitrogen, Carlsbad, CA). qRT-PCR was conducted to quantify different viral 138 
transcripts using primers described previously (23). The mRNA level of the 139 
housekeeping gene β-actin was used as a reference for normalization, using the primers 140 
5’ATTGCCGACAGGATGCAGA3’ (forward) and 141 
5’GAGTACTTGCGCTCAGGAGGA3’(reverse). All qRT-PCR reactions were carried 142 
out in triplicates.      143 
 144 
KSHV Virion Production and Titration 145 
 The culture supernatants of BCBL1-BAC36 cells were collected 5 days after 146 
culturing in RPMI 1640 medium plus 10% FBS and various concentrations of D-glucose, 147 
followed by low-speed centrifugation (4,000 g, 15 min) to remove cellular debris. To 148 
determine the relative viral titers in the supernatants, 1 ml of the supernatant was used to 149 
infect HUVECs in 6-well plates.  At 72 h post-infection, cells were harvested and 150 
counted with a hemocytometer under a fluorescent microscope.  The numbers of KSHV 151 
infected GFP-positive cells and the numbers of total cells from 8 independent readings 152 
were used to calculate the average percentage of GFP-positive cells, which was used as 153 
the relative viral titer of the supernatant in question. 154 
 155 
Chromatin Immuno-Precipitation (ChIP) Assay  156 
 Equal numbers of BCBL1-BAC36 cells (8 x 106 cells) were cultured in RPMI 157 
1640 medium with various concentrations of D-glucose with and without catalase  (400 158 
unites/ml) for 24 h, followed by fixation with 0.5% formaldehyde for 15 min.  Chromatin 159 
suspensions were prepared, and ChIP assays were performed using a ChIP assay kit 160 
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(Invitrogen) with antibodies to RNA polymerase II (RN Pol II), acetylated histone-4 161 
(H4K12-Ac), histone-3 (H3K9-Ac), histone-3 (H3), LANA, and rabbit IgG, all from 162 
Millipore, as well as a rat monoclonal antibody to LANA and a rat IgG (as control) as 163 
described above. DNA from input and the end ChIP products were isolated by using a 164 
DNA purification kit (QIAGEN). The purified DNA was re-suspended in 200 μl sterile 165 
water, and used for qPCR quantification for specific viral chromatin with the following 166 
primers:  5’CTCATCGTCGGAGCTGTCACACG3’ (RTA promoter-forward) and 167 
5’TCTCCCGATGGCGACGTGCACTAC3’ (RTA promoter-reverse) from RTA 168 
(ORF50) promoter region. 169 
 170 
Measurement of intracellular H2O2 171 
 BCBL1-BAC36 cells were cultured in RPMI 1640 medium plus 10% FBS with 1, 172 
3, and 6 g/L D-glucose for 24 hours. The cells were collected and washed twice with ice-173 
cold PBS, and re-suspended in 1 x assay buffer of the OxiSelect™ hydrogen 174 
peroxide/peroxidase assay kit from Cell Biolabs, Inc. (San Diego, California, USA) at a 175 
concentration of 2 x 106/ml.  The cells were homogenized by sonication, followed by 176 
high speed centrifugation (10,000 g, 15 minutes at 4ºC).  The supernatants and 1 x assay 177 
buffer (as background) were loaded into 96-well plate for measurement of the relative 178 
levels of H2O2, with 6 repeats per sample.  In parallel, a series of different concentrations 179 
(0 to 10 µM) of H2O2 were loaded into the same plate.  The florescence H2O2 detection 180 
reaction was read under a fluorescence microplate reader (BIO-TEK, Winooski, Vermont, 181 
USA) at 560 nm (excitation) and 600 nm (emission).  Upon subtraction of each reading 182 
with that of the background, a standard curve was established with relative fluorescence 183 
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units (RFU) from the different concentrations of H2O2, and the concentrations of H2O2 in the 184 
samples were determined by comparing RFU of the samples with the standard curve.  185 
 186 
RESULTS 187 
Cells cultured in high concentrations of D-glucose display increased KSHV lytic 188 
gene expression  189 
 To test the effect of high concentration of glucose on KSHV gene expression, we 190 
conducted independent experiments in three different laboratories.  The Wood laboratory 191 
cultured the original KSHV-infected BCBL1 cells in RPMI 1640 medium containing 1, 192 
3, and 6 g/L D-glucose, which are equivalent to 100, 300, and 600 mg/dL as measured by 193 
clinic glucose meters, respectively.  Clearly, BCBL1 cells expressed significantly higher 194 
levels of RTA and K8.1 mRNA (Fig. 1A), as well as RTA and K8α proteins when 195 
cultured in medium containing 3 and 6 g/L D-glucose (Fig. 1B and C).  196 
 Adding more D-glucose also changes the osmolality of the medium.  To rule out 197 
possible effect of osmolality on KSHV gene expression, the Gao and Ye laboratories 198 
cultured BCBL1 cells carrying the recombinant KSHV, BAC36 (24), in RPMI 1640 199 
medium containing 1, 3, and 6 g/L of D-glucose and 5, 3, and 0 g/L L-glucose, 200 
respectively. L-glucose, which cannot be metabolized by the cells, was used to balance 201 
the osmolality in medium with lower levels of D-glucose, in order for all cells to be 202 
compared with the same osmolality. As shown in Fig. 1E, F, and G, under these 203 
conditions, higher concentrations of D-glucose increased expression of RTA and ORF65 204 
in BCBL1-BAC36 cells.  Similar effects were also seen in TIVE-KSHV (BAC16) cells 205 
(Fig. 1D).  In addition, BCBL1-BAC36 cells cultured in high levels of D-glucose 206 
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produced higher titers of virions (Fig. 1H).  Collectively, these results indicate that high 207 
glucose enhances KSHV lytic gene expression and replication in different types of cells. 208 
 209 
Generation of hyperglycemic nude mice and xeno-grafting of TIVE-KSHV cells  210 
 To further examine the association between high blood glucose in diabetic KS 211 
patients and KSHV replication, we next generated hyperglycemic nude mice by using the 212 
commonly used antibiotic STZ.  Before treatment, the blood glucose level of each mouse 213 
was measured using a glucose meter.  All 32 mice had a blood glucose level within the 214 
normal range (100 to 140 mg/dL) (Fig. 2A).  The mice were then randomly divided into 215 
two groups.  One group of mice were injected with STZ at a dose of 200 mg/kg body 216 
mass, twice weekly for 2 weeks, and the second group were injected with a placebo 217 
(PBS). Two weeks after the treatment, we measured the blood glucose levels of all mice 218 
again.  All STZ-treated mice displayed permanent diabetic levels of blood glucose (Fig. 219 
2A) and symptoms of diabetes such as excessive thirst and loss of weight (Fig. 2B).   220 
 We then subcutaneously injected TIVE-KSHV (BAC16) cells at the abdominal 221 
region at a dose of 5 x 106 cells per injection site, two sites per mouse, into the two 222 
groups of mice for tumor development. Eight weeks after inoculation, we surgically 223 
collected the tumors. As shown in Fig. 2C and D, no significant difference in tumor 224 
volume was seen between the two groups, except two of the STZ-treated mice developed 225 
a secondary tumor at the neck region.  These secondary tumors had fewer cells that 226 
expressed KSHV latent protein LANA and contained large numbers of mouse 227 
inflammatory cells expressing the mouse macrophage marker F4/80 (data not shown).    228 
 229 
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TIVE-KSHV (BAC16) cells express higher levels of KSHV lytic genes in 230 
hyperglycemic mice 231 
 To examine how blood glucose level impacts viral gene expression, we isolated 232 
total RNA from 8 tumors from each group of mice and measured the mRNA levels of 233 
KSHV replication and transcription activator (RTA, ORF50) by qRT-PCR.  All tumors 234 
from STZ-treated mice express higher levels of RTA mRNA (Fig. 3A).  We then 235 
extracted total proteins from 8 tumors of each group and conducted Western blot analysis 236 
to measure viral proteins.  As shown in Fig. 3B, all 8 tumors from STZ-treated mice 237 
expressed much higher levels of RTA protein than the control mice.  To further confirm 238 
increased expression of KSHV lytic genes in tumors from STZ-treated mice, we 239 
performed immune-histochemical staining on sections of the other 8 tumors from each 240 
group with a monoclonal antibody to KSHV small capsid protein (ORF65).  As shown in 241 
Fig. 3C and D, the numbers of cells expressing ORF65 are 4.8 times higher in tumors 242 
from STZ-treated mice than in tumors from the control mice. 243 
 Since we waited two weeks after the last STZ treatment before injecting TIVE-244 
KSHV (BAC16) cells into the mice, it is unlikely that the increased expression of RTA 245 
and ORF65 resulted from STZ treatment itself.  To rule out that possibility, we cultured 246 
TIVE-KSHV (BAC16) cells in the absence or presence of STZ, followed by Western blot 247 
detection of RTA and LANA proteins.  As shown in Fig. 3E, STZ treatment had little 248 
effect on expression of RTA and LANA. Hence, the elevated levels of blood glucose in 249 
STZ-treated mice are responsible for the increased expression of KSHV lytic genes. 250 
 251 
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High concentrations of glucose enhances KSHV lytic gene expression by inducing 252 
H2O2 253 
 Metabolic syndromes including diabetes are well known for the production of 254 
excessive amounts of reactive oxygen species (ROS) such as H2O2 (25-30), which has 255 
previously been shown to trigger reactivation of latent KSHV into lytic replication (20-256 
21, 31).  To monitor changes in the level of intracellular H2O2, we used a previously 257 
established BCBL1 cell line that stably expresses the H2O2 sensor protein Hyper-cyto 258 
(21).  The Hyper-cyto protein exhibits two excitation peaks at 420 and 500 nm and one 259 
emission peak at 516 nm. Upon exposure to H2O2, the excitation peak at 420 nm 260 
decreases in proportion to the increase in the peak at 500 nm, and cells become yellow 261 
fluorescent when intracellular H2O2 surpasses the threshold level (32). We cultured these 262 
cells in RPMI 1640 medium containing 1, 3, and 6 g/L D-glucose for 24 hours 263 
respectively.  As shown in Fig. 4A and B, the intracellular level of H2O2 increased 264 
significantly when cells were cultured in higher concentrations of D-glucose.  To further 265 
confirm that high glucose induces H2O2 production, we cultured BCBL1-BAC36 cells in 266 
RPMI 1640 medium containing 1, 3, and 6 g/L D-glucose for 24 hours respectively, 267 
prepared cell lysates from equal numbers (2 x 106) of cells in 1 ml assay buffer, and 268 
measured their relative intracellular H2O2 concentrations by using a hydrogen 269 
peroxide/peroxidase assay kit from Cell Biolabs, Inc. Cells cultured in medium containing 3 270 
and 6 g/L D-glucose definitely produced higher levels of H2O2 (Fig. 4C).       271 
 To demonstrate that H2O2 was responsible for the increased KSHV lytic gene 272 
expression, we next cultured BCBL1-BAC36 cells in RPMI 1640 medium containing 1 273 
and 6 g/L D-glucose respectively, in the absence or presence of catalase or the 274 
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antioxidants N-acetyl-cysteine (NAC) and glutathione. As shown in Fig. 4D, catalase 275 
abolished high glucose-induced transcription of RTA and ORF65.  The three different 276 
antioxidants inhibited high glucose-induced expression of ORF65 protein in a dose-277 
dependent manner (Fig. 4E). Collectively, these results suggest that induction of KSHV 278 
lytic gene expression by high glucose is mediated by H2O2.  279 
 280 
High glucose down regulates class-III HDAC SIRT1 to increase histone acetylation 281 
and transactivate viral chromatins      282 
 We previously showed that H2O2 activated the MAP kinases ERK-1/2, JNK, and 283 
p38 to induce expression of KSHV lytic genes (21). Consistent with our previous finding, 284 
BCBL1-BAC36 cells cultured in medium containing high concentration of D-glucose 285 
displayed increased phosphorylation of ERK1/2, JNK, and p38 and expression of KSHV 286 
lytic protein RTA, which can be inhibited by catalase (Fig. 5A). In addition, inhibitors of 287 
ERK1/2, JNK, and p38 significantly inhibited high glucose induction of RTA 288 
transcription (Fig. 5B), thus confirming a critical role of MAPK activation in high 289 
glucose induction of RTA expression.  290 
To investigate other mechanisms that might be involved in high glucose induction 291 
of KSHV lytic replication, we examined the expression of SIRT1, which is a member of 292 
class-III HDAC and a key factor involved in the development of diabetes (33-39). In 293 
addition, several studies have demonstrated the involvement of SIRT1 in the regulation 294 
of KSHV lytic gene expression through epigenetic remodeling (40-42).  295 
Immuno-fluorescence antibody (IFA) staining showed that SIRT1 expression was 296 
substantially reduced in BCBL1-BAC36 cells cultured in medium containing 6 g/L D-297 
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glucose compared to cells cultured in medium containing 1 g/L D-glucose (Fig. 6A and 298 
B).  Consistent with the IFA results, data from Western blot analysis showed that the 299 
protein level of SIRT1 was reduced by D-glucose in a dose-dependent manner (Fig. 7A). 300 
To examine if H2O2 plays a role in SIRT1 down regulation, we cultured BCBL1-BAC36 301 
cells in medium containing low and high glucose in the presence of various doses of 302 
catalase. As shown in Fig. 7B, catalase dose-dependently blocked SIRT1 down regulation 303 
in cells that were cultured in medium containing 6 g/L D-glucose. In a parallel 304 
experiment, we found that treating BCBL1-BAC36 cells with H2O2 also resulted in 305 
SIRT1 down regulation, which could be blocked by catalase as well (Fig. 7C).  Together, 306 
these results suggest that H2O2 mediates SIRT1 down regulation in cells that are cultured 307 
in medium containing high concentration of glucose.     308 
As a consequence of SIRT1 down regulation, BCBL1-BAC36 cells cultured in 309 
medium containing high concentrations of D-glucose displayed increased levels of 310 
acetylated histones, which could be reduced by adding catalase to the culture medium 311 
(Fig. 7D).  To demonstrate that these epigenetic changes indeed occur in viral 312 
chromatins, we next conducted ChIP assays.  By performing qPCR using primers specific 313 
for the promoter region of KSHV lytic gene RTA, we detected significantly higher levels 314 
of acetylated histones and RNA polymerase II in this region of viral chromatin when cells 315 
were cultured in medium containing high concentrations of glucose (Fig. 5E and F).  316 
These results suggest that, in addition to activation of MAKP pathways, high glucose also 317 
transactivate KSHV lytic gene expression via epigenetic modifications of the RTA 318 
promoter region. 319 
 320 
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DISCUSSION 321 
 Multiple studies have reported high prevalence of classic KS in patients with 322 
diabetes mellitus (10-13), and KSHV DNA was detected in more than 50% of type-2 323 
diabetic patients (14-16).  These clinical studies seem to suggest that diabetes patients are 324 
more prone to KSHV infection and that diabetes is a risk factor for development of 325 
classic KS. However, whether this metabolic syndrome really contributes to KS tumor 326 
development has never been experimentally tested.  327 
 Type-1 diabetes results from insulin deficiency due to the lack of insulin-328 
producing β cells in the pancreas.  In contrast, type-2 diabetes occurs in adults as a 329 
consequence of the development of cellular resistance to insulin.  Despite the different 330 
mechanisms, a common outcome of both types of diabetes is high glucose levels in the 331 
plasma.  In the present study, we found increased levels of KSHV lytic gene expression 332 
when KSHV infected BCBL1 and TIVE-KSHV cells were cultured in media containing 333 
diabetic levels of glucose.  In full support of data from the in vitro study, TIVE-KSHV 334 
cells also displayed substantially higher expression of KSHV lytic genes in 335 
hyperglycemic mice than in mice with normal level of blood glucose. These results 336 
strongly suggest that high levels of blood glucose promote development of KS by 337 
inducing productive KSHV lytic replication. 338 
 One of the manifestations by metabolic syndromes such as obesity and diabetes is 339 
production of excessive levels of ROS (25-30). By using a previously established BCBL1 340 
cell line that stably expressing the H2O2 sensor protein pHyper-cyto (21), we 341 
demonstrated that cells cultured in high concentrations of glucose produce increased 342 
levels of intracellular H2O2. This result was further confirmed by another intracellular 343 
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H2O2 measurement assay. Notably, addition of catalase, which converts H2O2 into H2O 344 
and O2, and the anti-oxidants NAC and glutathione, effectively blocked high glucose 345 
induction of KSHV lytic gene expression in a dose-dependent manner.  Therefore, H2O2 346 
mediates high glucose induction of KSHV lytic gene expression, which further supports 347 
previous reports that H2O2 is an important physiological factor involved in reactivation of 348 
latent KSHV (20-21, 31).  Interestingly, H2O2 has also been shown to enhance viral entry 349 
(43-45). It is therefore highly possible that the hyperglycemic environment in diabetic KS 350 
patients contributes to development of KS by promoting both productive KSHV 351 
replication and recurrent de novo infection. 352 
Similar to stimulation with H2O2 (21), culturing cells in medium containing high 353 
concentrations of D-glucose also activates ERK1/2, JNK, and p38, and inhibitors of these 354 
MAPK pathways inhibit high glucose induction of KSHV gene expression.  Interestingly, 355 
we found that high glucose and H2O2 also cause down regulation of the class-III HDAC 356 
SIRT1, leading to increased levels of histone acetylation in the promoter region of KSHV 357 
key lytic gene RTA. Thus, high glucose also engages this epigenetic mechanism to 358 
promote KSHV lytic gene expression. SIRT1 is well known for its anti-aging, anti-359 
oxidative stress, and anti-inflammation properties (22, 46-47), and down regulation of 360 
SIRT1 has been linked to development of diabetes (48). Suppression of SIRT1 has been 361 
shown to trigger reactivation of latent KSHV (42, 49). SIRT1 is a member of the Sirtuin 362 
protein family that couples histone lysine deacetylation to NAD hydrolysis (50-52). The 363 
dependence of SIRT1 on NAD links its enzymatic activity directly to the energy status of 364 
cells via the cellular NAD to NADH ratio, the absolute levels of NAD, NADH or 365 
nicotinamide, or a combination of these variables.   366 
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The development of KS is a complex process. KSHV infection resulting from 367 
productive lytic replication plays an essential role in the initiation and progression of KS. 368 
However, in already formed KS tumors, KSHV-infected tumor cells are predominantly 369 
latent (53). Inflammatory cytokines, stress, and ROS are known to stimulate KSHV 370 
reactivation from latency (54).  Under highly inflammatory and stressful conditions such 371 
as diabetes, it is expected that the latent virus undergoes reactivation.  In this study, we 372 
xeno-grafted the KS tumor model cell line TIVE-KSHV (BAC16) into normal and 373 
hyperglycemic nude mice.  While no obvious difference in tumor growth was seen 374 
between the two groups of mice, we did find significantly higher numbers of TIVE-375 
KSHV (BAC16) cells undergoing lytic replication in hyperglycemic mice than in normal 376 
mice.  Nevertheless, the majority of TIVE-KSHV cells in tumors from hyperglycemic 377 
mice remain latently infected, suggesting that the virus might have evolved unique 378 
mechanisms to overcome the highly inflammatory and stressful conditions to maintain 379 
latency.  One possible mechanism might be through modulation of the cellular metabolic 380 
status. In support to this hypothesis, our recent study demonstrated that KSHV inhibits 381 
cellular aerobic glycolysis and oxidative phosphorylation by inhibiting expression of 382 
GLUT1 and GLUT3, thus preventing overflow of the metabolic pathways and 383 
maintaining the homeostasis of the latently infected and malignantly transformed cells 384 
(55).  385 
In summary, our study provides the first evidence for a link between diabetes and 386 
higher levels of KSHV replication, which may lead to development of classic KS.  Our 387 
results highlight H2O2 as the mediator for high glucose induction of KSHV lytic 388 
 o
n
 August 17, 2016 by UNIV O
F NEBRASKA-LINCO
LN
http://jvi.asm.org/
D
ow
nloaded from
 
  18
replication through multiple mechanisms, which may shed lights on development of new 389 
strategies to prevent KSHV infection and KS development in diabetic patients.  390 
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 402 
FIGURE LEGENDS 403 
Figure-1. Cells cultured in medium containing higher concentrations of D-glucose 404 
express increased levels of KSHV lytic genes.  A, relative levels of RTA and K8.1 405 
mRNAs in BCBL1 cells that were cultured in RPMI 1640 medium containing 1, 3, and 6 406 
g/L D-glucose (D-Glu) for 24 hours respectively.  B, Western blot detection of RTA and 407 
K8α proteins from BCBL1 cells treated as described in A. C, relative levels of RTA and 408 
K8α protein in Western blots shown in B.  The intensity of RTA or K8α band from each 409 
sample was first normalized to that of the β-tubulin band from the same sample.  The 410 
levels of RTA and K8α proteins in cells cultured in medium containing 1 g/L D-glucose 411 
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were then set as the reference with a value of 1.0, and the relative levels of these proteins 412 
in other cells were the ratios between their band intensities and that of the reference.  D, 413 
relative levels of RTA and ORF57 mRNAs in TIVE-KSHV cells cultured in DMEM 414 
medium containing 10% FBS and 1 or 6 g/L D-glucose (D-Glu) plus 5 or 0 g/L L-glucose 415 
(L-Glu) respectively.  E, relative levels of ORF50 (RTA) and ORF65 mRNAs in 416 
BCBL1-BAC36 that were cultured in RPMI 1640 medium containing 10% FBS and 1, 3, 417 
or 6 g/L D-glucose (D-Glu) plus 5, 3, or 0 g/L L-glucose (L-Glu) for 24 hours (for RTA 418 
mRNA) and 72 hours (for ORF65 mRNA), respectively. F, Western blot detection of 419 
RTA and ORF65 proteins from BCBL1-BAC36 cells treated as described in E; G, 420 
relative levels of RTA and ORF65 proteins in Western blots shown in F, which were 421 
calculated as described in C.  H, percentages (%) of GFP-positive HUVECs at 48 hours 422 
post infection (hpi) with supernatant from equal numbers (8 x 106) of BCBL1-BAC36 423 
cells that were cultured in RPMI 1640 medium containing 10% FBA, 1, 3, or 6 g/L D-424 
glucose (D-Glu) plus 5, 3, or 0 g/L L-glucose (L-Glu) for 5 days respectively.  All qRT-425 
PCR reactions consisted of triplicates, and the differences in relative mRNA levels (fold) 426 
of RTA, ORF57, K8.1, and ORF65 between cells cultured in medium containing 1 g/L 427 
D-glucose and those cultured in medium containing 3 or 6 g/L D-glucose were all 428 
significant with P values < 0.005.  429 
 430 
Figure-2. Generation of hyperglycemic nude mice and xeno-grafting TIVE-KSHV 431 
(BAC16) cells for tumor development. A total of 32 athymic nude mice (4 weeks old, 432 
female) were randomly separated into two groups, with one group of mice being treated 433 
with STZ (200 mg/kg body mass, 2 IP injections per week, for 2 weeks) to develop 434 
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hyperglycemia and the other group of mice injected with PBS (placebo) as a control. 435 
Equal numbers (5x106/injection site, 2 sites/mouse) of TIVE-KSHV (BAC16) cells were 436 
subcutaneously injected into the mice for tumor development two weeks after the last 437 
STZ treatment. A, average blood glucose levels of STZ-treated mice and un-treated mice 438 
(control) measured at 4 and 12 weeks after the first STZ treatment. B, average weights of 439 
the two groups of mice at 2 and 12 weeks after the first STZ treatment. C, representative 440 
tumors from the two groups of mice collected at the end of experiment. D, average 441 
volumes (length x width x height) of tumors from the two groups of mice at different 442 
week post inoculation of TIVE-KSHV (BAC16) cells.  443 
 444 
Figure-3.  Tumors from hyperglycemic mice express significantly higher levels of KSHV 445 
lytic gene expression. A, average mRNA levels of KSHV lytic gene ORF50 (RTA) from 446 
8 tumors of STZ-treated and untreated (control) mice respectively. B, Western blot 447 
detection of lytic protein RTA and latent protein LANA from 8 tumors of each group. β-448 
tubulin was used as loading control. C, immuno-chemical staining of KSHV small capsid 449 
protein (ORF65) and LANA on tumors from three STZ-treated and three control mice 450 
(M1, M2, and M3). Staining with mouse or rat IgG was done in parallel as a negative 451 
control.  D, average numbers of ORF65-positive cells per microscopic field in tumor 452 
sections from the two groups of mice. E, Western blot detection of RTA and LANA 453 
proteins from TIVE-KSHV (BAC16) cells that were cultured with and without STZ (1 454 
μM) and TPA (25 ng/ml) for 24 hours respectively.       455 
 456 
 457 
 o
n
 August 17, 2016 by UNIV O
F NEBRASKA-LINCO
LN
http://jvi.asm.org/
D
ow
nloaded from
 
  21
Figure-4.  High glucose induces H2O2 to induce KSHV lytic gene expression. A and B, 458 
BCBL1 cells stably expressing the H2O2 sensor protein pHyper-cyto were used to 459 
measure the relative levels of intracellular H2O2. The number of cpYFP-positive cells (A) 460 
and fluorescence intensity (B) were quantified by flow cytometry analysis, following a 24 461 
hours culture in RPMI 1640 medium containing 10% FBS and 1 (red), 3 (green), or 6 462 
(purple) g/L D-glucose respectively. Regular BCBL1 cells cultured in RPMI 1640 463 
medium containing 10% FBS and 2 g/L D-glucose were used as a background control for 464 
flow cytometry analysis (black). Culture with each glucose concentration consisted of 6 465 
replicates. C, relative intracellular H2O2 concentrations from equal numbers (2 x106) of 466 
BCBL1-BAC36 cells that were cultured as described in A and B. Measurement of H2O2 467 
was carried out by using the OxiSelect™ hydrogen peroxide/peroxidase assay kit from Cell 468 
Biolabs, Inc.  D, ORF50 (RTA) and ORF65 mRNA levels in BCBL1-BAC36 cells 469 
cultured in RPMI 1640 medium containing 1 or 6 g/L D-glucose (D-Glu) in the presence 470 
or absence of 400 U/ml of catalase (Cat) for 24 h (for RTA mRNA) and 72 h (for ORF65 471 
mRNA) respectively. Differences in mRNA levels between cells cultured in medium 472 
containing 1 g/L and those cultured in medium containing 6/L D-glucose or between 473 
culture with and without catalase were all significant with P values <0.005.   E, Western 474 
blot detection of KSHV small capsid protein (ORF65) in BCBL1-BAC36 cells cultured 475 
in RPMI 1640 medium containing 1 or 6 g/L D-glucose (D-Glu) in the presence of 476 
different doses of catalase and antioxidants NAC and glutathione for 72 hours 477 
respectively. 478 
 479 
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Figure-5. High glucose activates MAPK pathways to induce KSHV gene expression.  A, 480 
Western blot detection of ERK-1/2, JNK, p38, and their phosphorylated counterparts, as 481 
well as RTA and β-tubulin in BCBL1-BAC36 cells that were cultured in RPMI 1640 482 
medium containing 1 or 6 g/L D-glucose (D-Glu), or stimulated with 400 µM H2O2, in 483 
the presence or absence of 200 U/ml catalase (Cat) for 24 hours.  B, levels of RTA 484 
mRNA in BCBL1-BAC36 cells that were cultured in RPMI 1640 medium with 1 or 6 g/L 485 
D-glucose (D-Glu) in the presence or absence of the different MAPK inhibitors for 24 486 
hours.  Concentrations of the inhibitors were as described previously (21). 487 
 488 
Figure-6. High glucose down regulates expression of class-3 HDAC SIRT1. A, IFA 489 
staining of SIRT1 (red) in BCBL1-BAC36 cells cultured in RPMI 1640 medium 490 
containing 10% FBS and 1 or 6 g/L D-glucose for 24 h, using a mouse monoclonal 491 
antibody to SIRT1 and a rabbit anti-mouse IgG conjugated to Alexa Fluor®-594.  DAPI 492 
was used for nuclear staining. The cells were imaged and analyzed under a fluorescence 493 
microscope with a 40x oil objective. B, average numbers of SIRT-1 foci (red dot) per cell 494 
when cells were cultured at different concentrations of D-glucose. 495 
 496 
Figure-7. H2O2 mediates high glucose down regulation of SIRT1 to epigenetically 497 
activate expression of KSHV lytic gene RTA.  A and B, Western blot detection of SIRT1 498 
protein in BCBL1-BAC36 cells that were cultured in RPMI 1640 medium containing 499 
10% FBS and 1, 3, or 6 g/L D-glucose (D-Glu) for 24 h, in the absence (A) or presence 500 
(B) of various doses of catalase (Cat). C, Western blot detection of SIRT1 protein in 501 
BCBL1-BAC36 cells treated with different doses of H2O2 and catalase (Cat). D, Western 502 
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blot detection of acetylated histone-3 (H3K9-Ac) and histone-4 (H4K12-Ac), total 503 
histone-3 (H3) and histone-4 (H4), RTA and β-tubulin in BCBL1-BAC36 cells that were 504 
cultured in RPMI 1640 medium containing 10% FBS and 1, 3, or 6 g/L D-glucose (D-505 
Glu) in the presence or absence of 400 U/ml catalase (Cat) for 24 h.  E and F, ChIP assay 506 
detection of acetylated histones (H3K9-Ac and H4K12-Ac) and RNA polymerase II (RN 507 
Pol) in RTA promoter in BCBL1-BAC36 cells that were cultured with different 508 
concentrations of D-glucose (D-Glu) with and without 400 U/ml catalase (Cat) for 24 h.  509 
The relative amount of DNA in RTA promoter (RTA) from each ChIP reaction was 510 
determined by qPCR and calculated as the average ratio between the level of ChIP 511 
product and that of the input DNA from three repeats (F).  Real-time PCR products from 512 
inputs and ChIP assays were also analyzed in a 1.5% agarose gel (E). Differences in the 513 
levels of H3K9-Ac, H4K12-Ac, and RN Pol in RTA promoter between cells cultured in 514 
medium containing 1 g/L and 3 or 6 g/L D-glucose, or between cells cultured with and 515 
without catalase, were all significant with P values <0.005.   516 
 517 
 518 
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